It looks like a private company with strong links to India and offices in the US and Mexico. A team of 7 management and 10 advisory doctors. That doesn't diminish it as a competitor but raises questions about funding requirements. I see there is no government backing for the trials they are doing on CV-19.
It looks like a private company with strong links to India and...
-
- There are more pages in this discussion • 15,581 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.035(3.72%) |
Mkt cap ! $1.110B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $2.550M | 2.663M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 111876 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 46145 | 13 |
View Market Depth
| Last trade - 14.16pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |